Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2020 May;72(5):622–629. doi: 10.1002/acr.23887

Table 3.

Factors associated with severe manifestations of SLE in multivariable Cox proportional hazards regression, among prevalent SLE cases in San Francisco County, 2007 – 2009

Lupus Nephritis* Thrombocytopenia Neuropsychiatric** APS Combined
Variables HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Race/ethnicity
  Non-Hispanic White reference reference reference reference reference
  Non-Hispanic Black 2.4 (1.6 − 3.8) 2.3 (1.1 − 4.4) 1.5 (0.8 − 2.9) 1.5 (0.7 − 3.0) 1.6 (1.1 − 2.2)
  API 4.3 (2.9 − 6.4) 2.3 (1.3 − 4.2) 1.1 (0.6 − 2.0) 2.5 (1.4 − 4.4) 2.4 (1.8 − 3.2)
  Hispanic 2.3 (1.4 −3.8) 2.2 (1.1 − 4.7) 1.0 (0.4 − 2.5) 2.6 (1.3 − 5.1) 1.4 (0.9 − 2.1)
Sex
  Female reference reference reference reference reference
  Male 1.6 (1.1 − 2.4) 2.1 (1.2 − 3.6) 1.8 (0.9 − 3.6) 1.4 (0.7 − 2.6) 1.8 (1.3 − 2.5)
Age, yr at diagnosis
  ≤18 1.1 (0.8 − 1.5) 1.0 (0.6 − 1.8) 1.1 (0.6 − 2.2) 1.1 (0.6 − 1.8) 0.9 (0.7 − 1.2)
  19–29 reference reference reference reference reference
  30–39 0.8 (0.5 − 1.2) 0.7 (0.4 − 1.4) 0.8 (0.4 − 1.8) 0.7 (0.4 − 1.4) 0.8 (0.5 − 1.1)
  40–49 1.0 (0.6 − 1.5) 0.5 (0.2 − 1.1) 1.2 (0.5 − 2.8) 0.7 (0.4 − 1.6) 0.9 (0.7 − 1.4)
  50+ 1.0 (0.6 – 1.5) 1.6 (0.9 − 2.8) 1.7 (0.8 − 4.0) 1.0 (0.5 − 2.0) 1.4 (1.0 − 2.0)

Calculations based on Cox proportional hazards model that contained each of race/ethnicity, sex, and age at diagnosis.

API = Asian/Pacific Islander, APS = antiphospholipid antibody syndrome, Combined outcome = any of lupus nephritis, thrombocytopenia, neuropsychiatric, or APS. HR = hazard ratio. Higher hazards indicate a shorter time to development of specific manifestations.

*

Any of the following surrogate labs were used to define lupus nephritis: 24 hour urine for protein > 500mg, 24 hour urine protein/creatinine ratio > 0.5, or spot protein/creatinine ratio > 0.5.

**

Neuropsychiatric lupus manifestations studied include: seizures, psychosis, and acute confusional state.